Cipla Limited

NSEI:CIPLA Stock Report

Market Cap: ₹1.2t

Cipla Past Earnings Performance

Past criteria checks 5/6

Cipla has been growing earnings at an average annual rate of 21.3%, while the Pharmaceuticals industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 9% per year. Cipla's return on equity is 16.8%, and it has net margins of 19.3%.

Key information

21.34%

Earnings growth rate

21.30%

EPS growth rate

Pharmaceuticals Industry Growth17.49%
Revenue growth rate9.02%
Return on equity16.84%
Net Margin19.34%
Next Earnings Update25 Jul 2025

Recent past performance updates

Recent updates

Here's Why Cipla (NSE:CIPLA) Has Caught The Eye Of Investors

Jul 13
Here's Why Cipla (NSE:CIPLA) Has Caught The Eye Of Investors

Here's Why Cipla (NSE:CIPLA) Can Manage Its Debt Responsibly

Jun 03
Here's Why Cipla (NSE:CIPLA) Can Manage Its Debt Responsibly

Earnings Beat: Cipla Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

May 16
Earnings Beat: Cipla Limited Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Cipla Limited (NSE:CIPLA) Investors Are Less Pessimistic Than Expected

Apr 15
Cipla Limited (NSE:CIPLA) Investors Are Less Pessimistic Than Expected

With EPS Growth And More, Cipla (NSE:CIPLA) Makes An Interesting Case

Mar 25
With EPS Growth And More, Cipla (NSE:CIPLA) Makes An Interesting Case

These 4 Measures Indicate That Cipla (NSE:CIPLA) Is Using Debt Safely

Feb 17
These 4 Measures Indicate That Cipla (NSE:CIPLA) Is Using Debt Safely

Why Investors Shouldn't Be Surprised By Cipla Limited's (NSE:CIPLA) Low P/E

Jan 13
Why Investors Shouldn't Be Surprised By Cipla Limited's (NSE:CIPLA) Low P/E

We Ran A Stock Scan For Earnings Growth And Cipla (NSE:CIPLA) Passed With Ease

Dec 07
We Ran A Stock Scan For Earnings Growth And Cipla (NSE:CIPLA) Passed With Ease
author-image

Aspirational Inhalation Launches And African Expansion Propel Growth Ambitions

Planned respiratory therapies and product launches could drive increased revenue and enhance the chronic therapy segment's growth.

Cipla Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Nov 01
Cipla Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Cipla Limited's (NSE:CIPLA) Share Price Could Signal Some Risk

Sep 29
Cipla Limited's (NSE:CIPLA) Share Price Could Signal Some Risk

Revenue & Expenses Breakdown

How Cipla makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NSEI:CIPLA Revenue, expenses and earnings (INR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 25272,67452,72561,0670
31 Dec 24267,20149,89758,6400
30 Sep 24262,64244,75157,3450
30 Jun 24258,92243,03556,1780
31 Mar 24255,36741,21654,9010
31 Dec 23251,16337,08253,7570
30 Sep 23243,40734,53252,5630
30 Jun 23235,10831,11251,2600
31 Mar 23225,59328,01950,1510
31 Dec 22222,18726,38348,9470
30 Sep 22218,87425,66048,1840
30 Jun 22216,10524,88435,9840
31 Mar 22217,07825,16846,6690
31 Dec 21210,71825,68143,2850
30 Sep 21207,61625,87643,0040
30 Jun 21202,80125,41742,4350
31 Mar 21191,20524,04941,2810
31 Dec 20188,77922,37440,4320
30 Sep 20180,80218,40339,4440
30 Jun 20174,37716,46238,8510
31 Mar 20170,80515,46538,6940
31 Dec 19171,20616,67838,6080
30 Sep 19167,57216,48938,3310
30 Jun 19163,73315,54637,8370
31 Mar 19163,23215,27737,4150
31 Dec 18155,22413,39135,6830
30 Sep 18154,28714,07435,0780
30 Jun 18154,99214,53034,5640
31 Mar 18151,05314,10534,1510
31 Dec 17147,61811,70132,9730
30 Sep 17144,95111,44432,7300
30 Jun 17141,63710,76232,8750
31 Mar 17143,34010,06433,0110
31 Dec 16142,50911,21331,5540
30 Sep 16137,54710,07131,0120
30 Jun 16134,33512,21930,0890
31 Mar 16135,48013,60029,2580
31 Dec 15135,04416,84739,0281,120
30 Sep 15131,63316,69438,2201,120
30 Jun 15124,78215,36837,0961,120
31 Mar 15113,45411,80823,5490
31 Dec 14106,19511,81832,1561,058
30 Sep 14105,62711,38331,3331,058

Quality Earnings: CIPLA has high quality earnings.

Growing Profit Margin: CIPLA's current net profit margins (19.3%) are higher than last year (16.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: CIPLA's earnings have grown significantly by 21.3% per year over the past 5 years.

Accelerating Growth: CIPLA's earnings growth over the past year (27.9%) exceeds its 5-year average (21.3% per year).

Earnings vs Industry: CIPLA earnings growth over the past year (27.9%) exceeded the Pharmaceuticals industry 16.4%.

Return on Equity

High ROE: CIPLA's Return on Equity (16.8%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/22 00:52
End of Day Share Price 2025/07/22 00:00
Earnings2025/03/31
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Cipla Limited is covered by 73 analysts. 35 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ashwin MehtaAmbit Capital
Prashant NairAmbit Capital
Nitin BhasinAmbit Capital